Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
about
Epigenetic effects of green tea polyphenols in cancerEnvironmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer PreventionEpigenetic diet: impact on the epigenome and cancerEpigenetic modulators as therapeutic targets in prostate cancerThe epigenomics of cancerDNA methyltransferases: a novel target for prevention and therapy.Identification of novel DNA methylation inhibitors via a two-component reporter gene system.Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.Chronic prenatal hypoxia induces epigenetic programming of PKC{epsilon} gene repression in rat hearts.Epigenetic modifications by dietary phytochemicals: implications for personalized nutritionCurrent limitations and future opportunities for epigenetic therapies.Targeting DNA methylation for epigenetic therapy.Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.Foetal nicotine exposure causes PKCĪµ gene repression by promoter methylation in rat hearts.Curcumin modulates DNA methylation in colorectal cancer cells.DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients.DNA demethylating antineoplastic strategies: a comparative point of viewInduction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.Epigenomics and ovarian carcinoma.Epigenetic activities of flavonoids in the prevention and treatment of cancerEpigenetic regulation of prostate cancerOral and intravenous pharmacokinetics of 5-fluoro-2'-deoxycytidine and THU in cynomolgus monkeys and humansTargeting the epigenome with bioactive food components for cancer preventionp300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma.Inhibition of cancer cell proliferation by 5-fluoro-2'-deoxycytidine, a DNA methylation inhibitor, through activation of DNA damage response pathway.DNA methylation: its role in cancer development and therapy.DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cellsChromatin, cancer and drug therapies.Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells.Role of gene methylation in antitumor immune response: implication for tumor progression.DNA methylation as clinically useful biomarkers-light at the end of the tunnelModulation of DNA methylation by a sesquiterpene lactone parthenolide.Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.Reversal of hypermethylation and reactivation of genes by dietary polyphenolic compoundsProcaine inhibits the proliferation and DNA methylation in human hepatoma cellsHLA antigen changes in malignant cells: epigenetic mechanisms and biologic significanceTargeting DNA methylation.Direct effect of cocaine on epigenetic regulation of PKCepsilon gene repression in the fetal rat heart.Aging and epigenetic drift: a vicious cycle.
P2860
Q24568216-52FC0525-C82A-4057-986D-577915676817Q26784500-54F6A8E8-56A2-40E8-9FF6-22B7426B56A3Q27022002-EBF53E27-405F-4D22-86D3-415E24504EDEQ28071912-4F223146-D7F9-4088-B042-7E4A2E512126Q28289975-BF88577E-7847-49D2-8E96-BA30E76357ABQ33579896-A5C5D36B-98CB-419B-90CE-8D563B2C3A30Q33789556-66029031-FBE7-4176-86E4-952EFAA6C463Q33845027-AC630C3B-E486-4B9A-8699-0D067BC6F25EQ34056312-8F1D2D68-AB2B-4F8E-8F72-33DCC2F956CDQ34129835-DA29FFE0-6541-437E-BCD3-2D402DC3E077Q34195077-780ACAEC-3672-4561-90EA-52C95780DF1AQ34258037-11A90422-14CA-4228-83F7-001C8768A924Q34279875-4EA8B80E-0E08-498A-A622-3EB8725DEE63Q34410283-3612398A-692A-4156-A7C2-F8A10BAB4130Q34608782-BED76880-FBBA-463D-BD92-AE6495BBCE89Q34930032-E9700D76-EF85-46E2-98D3-F60D5A783DE9Q34972245-1F65F299-878B-440B-A5C7-2EF69A01D890Q35110633-F23BF7FC-5050-4F34-B6EC-A7601BE0291BQ35232360-0D239ADD-DD3E-47F0-B05D-22020A770E09Q35636575-2BC708F0-96CB-4BD6-A842-7C171A579CD0Q35835175-C1314FF6-31B9-4C30-9513-FA5C961DB67FQ36001910-3FE6BF7B-6CF4-490A-8CD3-E03DD9600E4AQ36070627-A599DC14-6347-4D1B-85D5-9973B1A33137Q36072083-81422909-A181-4DC4-A20C-A08FD2FF633FQ36172205-4A95CA8F-824F-4C06-82EB-77A068D7F2DDQ36589313-EFD4240D-F4DE-43EA-A86D-F45EA310439AQ36986433-7FEFB988-A8E5-412C-8EC6-DDEF03C7B3E9Q37016577-CF476EBD-AC6F-488F-86A9-A709FCEDE920Q37073231-DDC2AD6F-8E19-4DA6-88C5-DF96D8B5A17BQ37126117-FCB8C3EB-CCEC-45B2-A4A8-E269DAA430D4Q37132658-9A185C4F-82B1-44AD-AE46-48352D8B23A4Q37148677-C0984D88-15C8-485D-A0EB-FDB2369B12F4Q37168514-1BE01AAF-06A4-44BE-8925-01A94EA096C9Q37184917-302F8A4D-DE40-4D54-8345-7D045F57DEF7Q37233158-8AFA0782-7A91-4475-B1E0-445914129988Q37278080-040285FC-2C1C-46FE-AD89-62B6328B9399Q37287152-04F4E579-4459-41FD-A07E-A6B6EED18708Q37320354-46520550-E74B-4EA4-9561-A66916C736FAQ37336170-937FEEB5-2467-4EB7-98F1-F7CE791D0FEAQ37410585-C419E63F-68CC-49A1-ADC3-716E45BCC5FD
P2860
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
description
2005 nĆ® lÅ«n-bĆ»n
@nan
2005幓ć®č«ę
@ja
2005幓č«ę
@yue
2005幓č«ę
@zh-hant
2005幓č«ę
@zh-hk
2005幓č«ę
@zh-mo
2005幓č«ę
@zh-tw
2005幓č®ŗę
@wuu
2005幓č®ŗę
@zh
2005幓č®ŗę
@zh-cn
name
Comparison of biological effec ...... versus 5-aza-2'-deoxycytidine.
@en
type
label
Comparison of biological effec ...... versus 5-aza-2'-deoxycytidine.
@en
prefLabel
Comparison of biological effec ...... versus 5-aza-2'-deoxycytidine.
@en
P2093
P1476
Comparison of biological effec ...... versus 5-aza-2'-deoxycytidine
@en
P2093
Allen S Yang
Christine B Yoo
Jennifer M Kwan
Jody C Chuang
Peter A Jones
Tony W H Li
P304
P356
10.1158/1535-7163.MCT-05-0172
P577
2005-10-01T00:00:00Z